rexresearch.comTSTO REPORTS
TetraSilver
TetrOxide ( TSTO )
https://www.ncbi.nlm.nih.gov/pubmed/22108474
Panminerva Med. 2011 Sep;53(3 Suppl 1):29-33.
Silver oxide ointment wound dressing in
venous ulcerations: home, self-management
Belcaro G1, Cesarone MR, Errichi BM, Ricci A, Antelman P, Dugall M, Pellegrini L, Ledda A, Viscardi G.
Belcaro G1, Cesarone MR, Errichi BM, Ricci A, Antelman P, Dugall M, Pellegrini L, Ledda A, Viscardi G.
Abstract
AIM: Venous ulcers are a common, chronic medical and social problem. These ulcers are difficult to heal in most patients with sustained venous hypertension. This pilot product evaluation registry study has evaluated the efficacy and safety of an antimicrobial silver oxide wound dressing ointment ("Silver Oxide Ointment") as part of the treatment of 'difficult' venous ulcerations.
METHODS:
The study was conducted measuring the variations in the area of the ulceration and microcirculatory parameters.
RESULTS:
After four weeks, treatment with the Silver Oxide Ointment proved more effective than the 'best management' used in controls. Transcutaneous PO2 was increased (improved); Laser Doppler skin flux and transcutaneous PCO2 were improved (decreased). Also in the silver oxide group a significantly higher number of venous ulcers were completely healed at four weeks. The silver oxide ointment improved both the microcirculation and the healing rate of their ulcers. No significant tolerability problems were observed.
CONCLUSION:
In difficult venous ulcerations, local treatment with this Silver Oxide Ointment, as one component of the total wound dressing, improved microcirculation measurements and healing rate. Most of the treatments were done at home by the patients or by their tutors. This study indicates the important role of this type of treatment and indicates the need to plan larger and more prolonged studies.
https://www.ncbi.nlm.nih.gov/pubmed/20657533
Panminerva Med. 2010 Jun;52(2 Suppl 1):37-42.
Venous and diabetic ulcerations: management
with topical multivalent silver oxide ointment
Belcaro G, Cesarone MR, Errichi BM, Ricci A, Dugall M, Pellegrini L, Ledda A, Grossi MG.
Belcaro G, Cesarone MR, Errichi BM, Ricci A, Dugall M, Pellegrini L, Ledda A, Grossi MG.
Abstract
AIM: In addition to contemporary compression therapy, one of the therapeutic approaches is the use of a topical wound care agent. The goal of this pilot registry study is to evaluate the efficacy and safety of a uniquely designed ointment containing multivalent silver oxide (Ag4O4) in the healing of difficult diabetic or venous ulcerations.
METHODS: Patients who had ulcers resulting from chronic venous insufficiency or diabetes participated in this open-label, randomized registry study. All patients were evaluated by measuring both the area of the ulceration and microcirculatory parameters. 148 patients were included in the study and categorized into two main groups: venous ulcers and diabetic ulcers. Each main group was then randomized into two sub-groups: topical treatment with silver oxide ointment and the control group (standard cleaning and compression management methods, without silver ointment). All patients were treated with accepted cleaning and compression management. RESULTS. In subjects with venous ulcers: After 4 weeks, the silver treatment was more effective than the control group treatment: Skin PO2 was increased 2.1 times more than the control group (17.4% to 8.2%) and skin flux (RF) was improved 1.6 times more than the control group (-38.7% to -24.2%). The total surface area of the ulcer was significantly reduced in the silver treatment group by 1.9 times the control group (-88.7% to -46.9%). In addition, in the silver treatment group we observed complete closure of the ulceration in 42% of subjects compared to 22% in the control group (P=<0.05). In subjects with diabetic ulcers: after 4 weeks, the silver treatment was more effective than the control group treatment: Skin PO2 increased 2.6 times more than the control group (23.3% to 9.1%) and skin flux (RF) was significantly improved 4.3 times more than the control group(-26.7% to -6.2%). The total surface area of the ulcer was significantly reduced in the silver treatment group by 3.7 times the control group (-89.0% to -23.9%). In addition, in the silver treatment group we observed complete closure of the ulceration in 39% of subjects compared to 16% in the control group (P</=0.05).
CONCLUSION: This pilot study provides observational data on the efficacy of local treatment of ulcers with a multivalent silver oxide containing ointment. The silver ointment improved microcirculation and the healing rate of all 78 patients that were treated with multivalent silver ointment and closed twice as many ulcers in 4 weeks compared to the control groups (40.7% silver treatment compared to 19.4% for the control). This study demonstrates the feasibility of this type of treatment and provides evidence of efficacy to plan larger randomized controlled studies. The large number of patients that were helped in this study demonstrates the efficacy of multivalent silver oxide topical ointment and its important role in ulcer therapy.
https://www.ncbi.nlm.nih.gov/pubmed/22108474
Panminerva Med. 2011 Sep;53(3 Suppl 1):29-33.
Silver oxide ointment wound dressing in
venous ulcerations: home, self-management.
Belcaro G1, Cesarone MR, Errichi BM, Ricci A, Antelman P, Dugall M, Pellegrini L, Ledda A, Viscardi G.
Belcaro G1, Cesarone MR, Errichi BM, Ricci A, Antelman P, Dugall M, Pellegrini L, Ledda A, Viscardi G.
Abstract
AIM: Venous ulcers are a common, chronic medical and social problem. These ulcers are difficult to heal in most patients with sustained venous hypertension. This pilot product evaluation registry study has evaluated the efficacy and safety of an antimicrobial silver oxide wound dressing ointment ("Silver Oxide Ointment") as part of the treatment of 'difficult' venous ulcerations.
METHODS: The study was conducted measuring the variations in the area of the ulceration and microcirculatory parameters.
RESULTS: After four weeks, treatment with the Silver Oxide Ointment proved more effective than the 'best management' used in controls. Transcutaneous PO2 was increased (improved); Laser Doppler skin flux and transcutaneous PCO2 were improved (decreased). Also in the silver oxide group a significantly higher number of venous ulcers were completely healed at four weeks. The silver oxide ointment improved both the microcirculation and the healing rate of their ulcers. No significant tolerability problems were observed.
CONCLUSION: In difficult venous ulcerations, local treatment with this Silver Oxide Ointment, as one component of the total wound dressing, improved microcirculation measurements and healing rate. Most of the treatments were done at home by the patients or by their tutors. This study indicates the important role of this type of treatment and indicates the need to plan larger and more prolonged studies.
https://www.ncbi.nlm.nih.gov/pubmed/21861623
Future Microbiol. 2011 Aug;6(8):933-40. doi: 10.2217/FMB.11.78.
Antimicrobial effects of TiO(2) and Ag(2)O
nanoparticles against drug-resistant bacteria and leishmania
parasites.
Allahverdiyev AM, Abamor ES, Bagirova M, Rafailovich M.
Allahverdiyev AM, Abamor ES, Bagirova M, Rafailovich M.
Abstract
Nanotechnology is the creation of functional materials, devices and systems at atomic and molecular scales (1-100 nm), where properties differ significantly from those at a larger scale. The use of nanotechnology and nanomaterials in medical research is growing rapidly. Recently, nanotechnologic developments in microbiology have gained importance in the field of chemotherapy. Bacterial strains that are resistant to current antibiotics have become serious public health problems that raise the need to develop new bactericidal materials. Metal oxide nanoparticles, especially TiO(2) and Ag(2)O nanoparticles, have demonstrated significant antibacterial activity. Therefore, it is thought that this property of metal oxide nanoparticles could effectively be used as a novel solution strategy. In this review, we focus on the unique properties of nanoparticles, their mechanism of action as antibacterial agents and recent studies in which the effects of visible and UV-light induced TiO(2) and Ag(2)O nanoparticles on drug-resistant bacteria have been documented. In addition, from to previous results of our studies, antileishmanial effects of metal oxide nanoparticles are also demonstrated, indicating that metal oxide nanoparticles can also be effective against eukaryotic infectious agents. Conversely, despite their significant potential in antimicrobial applications, the toxicity of metal oxide nanoparticles restricts their use in humans. However, recent studies infer that metal oxide nanoparticles have considerable potential to be the first-choice for antibacterial and antiparasitic applications in the future, provided that researchers can bring new ideas in order to cope with their main problem of toxicity.
https://cynthiabarringtontetrasilver.wordpress.com/2012/02/29/autism-brains-have-dna-with-8-rna-viruses-which-may-be-inhibited-by-tetrasilver-tetroxide-us-pat-6485755/
Autism brains have DNA with 8 RNA viruses which may be inhibited by Tetrasilver Tetroxide
Hello parents and family members of autistic children:
I have found some interesting information about the RNA viruses associated with autism. RNA viruses for HIV and cancer are inhibited by Tetrasilver Tetroxide US Pat 5676977 and US Pat 6485755 respectively...
http://www.hivaidsguide.com/2011/09/tetrasil-imusil/
Tetrasil (Imusil)
Tetrasil, also known as Imusil, is a fake-AIDS cure that is based on tetrasilver tetroxide, a chemical used to clean pool water. Apparently, people are supposed to believe that because a tiny amount of this highly dangerous chemical kills bacteria and virii in swimming water, that a larger amount will kill infections in humans. Of course, it is well known that it is poisonous to drink rubbing alcohol. Not many people are familiar with tetrasilver tetroxide. This is like saying that because you can use rubbing alcohol to clean a cut or scrape, you should drink it to kill a cold virus. This ‘cure’ is more likely to poison the user than help fight the disease.
Of course, the marketers of Tetrasil, like most proponents of fake cures, can’t have a single explanation for how their cure works. Apparently the more extreme and outrageous the claims the better. So, in addition to the ‘fact’ that tetrasilver tetroxide is used in pool ‘proves’ that it is safe to ingest and will kill infections, these tiny molecules are actually machines that generate electricity and kill the AIDS virus, HIV, by zapping it with electricity. (This claim is straight from the US patent for Tetrasil, by the way. For those who don’t know – you can file a patent for anything, including a time machine that will take you to a non-existent universe. The patent office doesn’t care if the thing works, just if you are copying someone else. So if you ever see anyone waving around a patent as proof that their crazy claim is valid – all it proves it no one else was crazy enough to want to claim the idea.)
It is, however, very very interesting that the patent claims that Tetrasil cures AIDS by electrocuting HIV, since the patent is held by a ‘Dr’. Marvin S. Antelman, the maker of Tetrasil, who claims that HIV has nothing to do with AIDS! Alright ‘Dr.’ Antelman, I’ll give you the benefit of the doubt. Assuming that HIV has nothing to do with AIDS, how do you cure a disease by killing something that is totally unrelated to it?
You can’t. And you can’t cure AIDS without attacking HIV. Which is just one more proof that the so-called doctor doesn’t know what he is talking about and is just out to make a buck. Illogical claims like this can be sold to people if the seller talks fast enough and doesn’t give them time to stop and question the absurdity of it, but a legitimate health professional wants people to ask questions, wants to have problems pointed out so they can be corrected. And a legitimate health worker does not make ridiculous claims that directly contradict his OWN PATENT!
That isn’t the only difference between ‘Dr.’ Antelman and a legitimate health worker. There are quite a few more. Among them, a real researcher wants other people to test their findings, and make sure their medicines work. This is called ‘third party testing’. A researcher wants this for two reasons. First, someone else doing the testing in a different way can make sure they didn’t miss anything in their work. Second, it’s a promise to their customers – ‘I have let my work be examined by other people, who agree that it works and is safe.’ Apparently, ‘Dr.’ Antelman feels neither of these are valid concerns, as the company he keep proclaiming has tested Tetrasil and found it safe and effective, is one that he owns. So basically he is saying ‘I have tested my own invention and proved to myself that it is safe and will work – and you can take my word for it!’
Worse, it isn’t safe, as Antelman’s own reported test results prove. All but one of the people who took part in Antelman’s ‘clinical test’ of Tetrasil developed hepatomegaly or enlarged livers. An enlarged liver only happens when a person has developed a serious medical condition such as liver disease, congestive heart failure or cancer! Of course, ‘Dr’. Antleman insists that none of the test participants were harmed, and that an enlarged liver is not dangerous. No, an enlarged liver doesn’t endanger a person – but the problems that cause it DO! Of course, Antleman couldn’t be bothered to test for further problems that might have led his patients to develop hepatomegaly.
Yet this man, who wants us to take his word, has already contradicted himself about how his so-called ‘cure’ works and claims it is safe while publicly announcing that his test subjects developed medical problems. It’s hard to trust someone who won’t play straight, who contradicts himself, and is not open and aboveboard.
At this time, Tetrasil is banned in Zambia because it has no proven effects for people living with HIV. It is still legal to sell in America (people need to be able to disinfect their pools) but it is illegal to promote it as a treatment or preventative for any disease.
Key ingredients: Tetrasilver tetroxide
https://www.voanews.com/a/a-13-2007-05-27-voa5/405931.html
Zambia Bans Untested AIDS Cures
November 01, 2009In Zambia, the government has introduced a law to protect people infected with the AIDS virus, HIV, from drugs that could harm their health. The law will require all anti-AIDS medications coming into the country to undergo clinical testing before being sold on the local market. From Lusaka, Danstan Kaunda has the story.
Many HIV patients in Zambia have abandoned life-prolonging anti-retroviral drugs for what is said to be a miracle cure, called ‘Tetrasil.’
Tetrasil appeared on the local market shortly after a Zambian weekly newspaper published a story saying it can cure HIV with 21 days.
The tabloid quoted a controversial US-based California activist, Boyd Graves, who said over 10 HIV patients have been disease-free since January.
Graves has also said the U.S government manufactured the HIV virus in a lab – a charge disputed by the mainstream scientific community. According to the Atlanta-based Centers for Disease Control, a team of international researchers reported in 1999 that they had traced the origins of HIV-1, the predominant strain of HIV in the developed world, to chimpanzees in west equatorial Africa. The CDC's web page says, "The researchers believe that HIV-1 was introduced into the human population when hunters became exposed to infected blood." (www.cdc.gov/hiv/resources/qa/qa3.htm)
In response to the controversy over the alleged cure, the government of Zambia has banned a local chemist – a sister company to the tabloid that published the claims – from selling Tetrasil. The government has also banned any press advertisements for it.
Under the new law, the Pharmaceutical Regulatory Authority of the Ministry of Health will test the safety and efficacy of all drugs and natural remedies, whether they are western medications or locally available herbs.
Dr. Canisius Banda is a spokesperson in the Ministry of Health.
"A technical working group," he said, "will be put in place to study these claims through scientific scrutiny, and if the drug (Tetrasil) passes the tests, than we will find ways on how will it be rolled out to the public, because it has to be an orderly process. We are saying that about 1.6 million people in Zambia are living with the HIV virus. Seventy-six thousand of them are on ARVs (antiretrovirals), and about 200,000 need to be on them. So if the process is not managed properly there could be a stampede or chaos."
Banda said claims of a cure for HIV / AIDS are often false – and hurt efforts to protect those infected – like government programs to provide free anti-retrovirals to pregnant mothers.
"Derailing government programs is not a wise thing to encourage," he said, "because it can threaten national security, and again that is a criminal activity. We will continue with the measures in place, but also encourage people with these claims, so that they are submitted to the ministry for scientific verification."
Meanwhile, the Network of Zambian People Living with HIV and AIDS wants the government to arrest anyone found selling Tetrasil.
Zambia has one of Africa’s highest infection rates – with about 16 percent of its population of 11 million infected.
http://www.compassion-response.net/08Treatments/05Imusil.htm
Compassion-Response.net
US Patent Claiming CURE for AIDS (USP #
5,676,977)
In October 1977, the United States patented a "method for curing AIDS', US Patent # 5,676,977. The product is called TETRASIL/IMUSIL and is a one-time injection/infusion that eliminates bacterial pathogens in the blood system of an individual. It is this cheap and effective cure for AIDS that is the subject of my presentation.
As a 29-month recipient of this one time injection, I further submit that we have an effective and cheap remedy for AIDS that is ready now. Our goal in bringing this information to the international community is to serve as aconduit for the necessary global "double blind" efficacy clinical trials of this U.S. patented CURE for AIDS.
...Marantech has identified a number of Electron Jumping Compounds (EJCs) that have been found in independent laboratory testing to exhibit
antimicrobial activity. However, to date the bulk of Company testing of EJCs for pharmacological safety and efficacy has centred on tetrasilver
tetroxide, a multivalent metal oxide also known as Tetrasil..
Independent laboratory and clinical testing indicates that Tetrasil molecules selectively target and kill rapidly proliferating organisms (e.g., cancer cells and pathogenic micro-organisms) through a multitude of nano-level electrical discharges followed by physical combination (chelation), while leaving normal tissues generally unaffected. The unusual suspected kill method may thwart the development of pathogens resistant to Tetrasil therapy.
Antimicrobial Activity: It has been known for several years that Tetrasil is a potent antimicrobial agent that kills a broad spectrum of viruses, fungi, algae and bacteria (including drug resistant strains) in vitro at concentrations that have been certified safe by the EPA for usage in swimming pools ("EPA Levels").
Recent clinical studies commissioned by Marantech and conducted by Exetec Labs in Honduras, indicate that topically applied Tetrasil can
lead to dramatic improvements in such infection-caused skin conditions as acne, cold sores, herpes lesions, conjunctivitis, chickenpox,
shingles, dermal tuberculosis and ringworm.
Moreover, building on earlier informal testing against systemic infections (including Candida albicans, dysentery and AIDS), Exetec has
been commissioned to conduct clinical studies of Tetrasil as an intravenous treatment for AIDS and tuberculosis.
One may contact Dr. Antelman through the Weizmann Institute in Israel or through Antelman Technologies, POB 382, Rehovat, Israel. Email contact:
impy@netvision.net.il
For information about Tetrasil and Imusil, you are invited to look up the Marantech website at http://www.Marantech.com
Marantech is the company presently supplying Imusil.
Marantech contact information:
Marantech Holding, LLC, One Turks Head Place Suite 810, Providence, RI 02903, USA. Tel: (401) 223-3000 Fax: (401) 223-7000
http://www.thebody.com/Forums/AIDS/Meds/Archive/Alternative/Q169823.html
Nov 16, 2005
Tetrasilver - Not!
What ever happened to the Aids cure Tetrasilver Tetroxide (US Patent #5,676,977) which you commented about a few years ago. The company marantech is gone from the net and all discussion has stopped.
Response from Dr. Pierone
Although the company appears to have vanished there was a small study reported last year from Kinshasa on Tetrasilver Tetroxide (Imusil). Here is the link.
Actually not all the news was bad. Of the 3 subjects treated, one had a false positive HIV test with a negative HIV viral load at baseline this subject appears to have done quite well after treatment. The other 2 subjects who actually were infected with HIV did not so well with a consistent increase in viral load following Imusil.
http://www.curezone.com/forums/fm.asp?i=1394
http://www.thebody.com/Forums/AIDS/Meds/Archive/Alternative/Q154827.html
Tetrasilver Tetroxide (US Patent #5,676,977)
Dear Dr. Pierone, MD.
Recently you were asked online about the possibility that Tetrasilver Tetroxide was patented as a "cure" for AIDS/HIV. Your response was that it was a pesticide with "little hope" and you gave an EPA reference.
I would invite you to look at Dr. Marvin S. Antelman's background as a world renowned chemist, who patented the Tetrasilver, and now Tetracopper, TetraCobolt, (there are many other) Tetroxides multivalent crystal redox devices...as well as USPTO Patents pertaining to these devices as to their pharmaceutical efficacy against bacteria, fungus and viruses. Because these novel devices are miniature reduction/oxidation devices that have polyvalent cations in their crystall latices, they posess unique electrical activity, and activity against pathogens, unlike the mechanism of action of other anti-virals aimed at fusion inhibition or viral replication via those target sites (eg. cell surface receptors, GP41/GP120 or transcriptases) or the terrible toxic-poisons known as nucleoside-derivates...AZT might as well be the HIV equivalent to Uracil Mustard.
In your expert medical opinions, before to discount Ag404, Could you please review USPTO Patents (5,676,977)(6,645,531)(5,571,520) (5,336,499) & (6,258,385)...all relevant on Imusil (infusion) and Tetrasil(Tetrasil marketed as a topical ointment)..both Ag404...you're previous reference to the EPA compound was one of Dr. Antelman's earlier compounds used as an agent against bacteria in water sources. These newer compounds are formulated and being tested in vitro/vivo against HIV, Herpses, and other viral agents and bacteria and have shown great efficacy against the virus and associated infections in AIDS patients. You can contact Dr. Marvin S. Antelman yourself as well at the Weizmann Institute in Rehovot, Israel. impy@netvision.net.il.
I think its important to look at the data, the science, and the real possibility that the antivirals on the market including Fuzeon (Trimeris) may have a unique competitor that has fewer toxic effects, and a wide spectral activity against many human pathogens.
I would love to see/hear your response after reading thru those patents... If you would like to rephrase the reply to your last questionaire that it "doesn't look promising" after more thorough research, that would be delightful.
Not only is it "promising", it appears to work.
Best, Mark
Response from Dr. Pierone
I first thought that Tetrasil was just another harmless and ineffective treatment promoted by herb merchants. The patent reports are beyond imagination and show that this is really scary stuff!
Data are presented with intravenous infusions of Tetrasil in a clinic in Honduras for people with the "candidiasis etiological category of AIDS". Well, did they have HIV at all? One would never know from this "research report".
"All were terminal, some, however, were in moderate condition, and others in poor" What is this nonsense about terminal AIDS patients?
"...indicates whether hepatomegaly occurred. This was an unfortunate consequence of the treatment which resulted in enlarged livers in all patients except the second one" Unfortunate, indeed!
As I read this patent report detailing the "cure" or AIDS with Tetrasil my overwhelming sense was that the evidence presented would fail a 5th grade science project. But beyond that, the studies detailed were unethical to the exteme.
Stay away from this stuff like the plague!
See excepts below:
Five patients afflicted with AIDS of the candidiasis etiological category were segregated for Tetrasil treatment. The rationale for selecting them was based on facts presented in an article by Peter H. Duesberg and Brian J. Ellison entitled "Is The AIDS Virus A Science Fiction?" (Policy Review, Summer 1990 pp. 40-51).
Only the factual presentations of the article were utilized and the hypothesis of the authors was ignored. The facts presented in the article related to the method of selecting AIDS patients based on the five aforementioned etiological subgroups targeted by the CDC, and the evidence presented, that there is AIDS without HIV as well as with it so that an anti-viral agent in most instances will not necessarily restore the immunity system.
Evaluations with Tetrasil were conducted on AIDS patients at Lucha Contra el Sida, Comayaguela, Honduras. The patients two weeks prior to inoculation were removed from their AZT, AIDS therapy. Tetrasil was administered at approximately 40 PPM of blood volume per patient as a suspension in a proprietary buffer solution (pH=6.5), supplied by Holipharm Corporation.
The results of evaluations with candidiasis are tabulated in Table I under its disease category. All patients evaluated were terminal. Some, however, were in moderate (m) condition and others in poor (p) as designated in the Table. The I and F designations refer to initial and final values as shown. WBC indicates white cell blood count. The H column, following CD 8, indicates whether hepatomegaly occurred. This was an unfortunate consequence of the treatment which resulted in enlarged livers in all patients except the second one. Despite hepatomegaly, there was no interference with liver function.
http://www.mefeedia.com/entry/curing-aids-with-tetrasilver-tetroxide-molecular-crystal-dev/12308725/
Video -- http://youtube.com/?v=YfZotd7OG9c
Curing AIDS With Tetrasilver Tetroxide
Molecular Crystal Dev
For several years, Boyd Graves and Leonard Horowitz have spoken about HIV AIDS being manufactured and funded by the US government with the knowledge that it could be used to kill massive populations of humans. Since the mid-1980s, I have maintained that it is a race-specific weapon and even wrote about it being such in 1990-91. It was in 1996 that some scientists found this to be the case, linked to the CCR5 Delta 32 negative genetic mutation making it impossible for millions of whites to contract HIV AIDS. Such is not the case for Africans and Asians, the highest birthrate groups. I also indicated they manufactured a strain of the virus that targeted certain genetic characteristics with white homosexual men. The reason for the targeting of this group was because eugenicists discovered that where there is high homosexuality among whites, the birthrates are lower. The case I quoted in 1988-89 was with Denmark and Sweden, having the highest homosexuality rate and the lowest negative birthrate of all Western European countries. This videos main theme is about the patent, purported to be a cure for HIV AIDS. The text of this patent in this video is clear and readable. Barack Obama has stated publicly that it is absurd to believe the US government created the HIV AIDS. We did not press him about his wrong assumption because had he stated the truth, as most blacks know it to be, it would have politically stopped his run for the presidency. You can't bring about big changes if you're not the president. It is now different and we're going to press this very, very serious issue far more devastating to Blacks around the world. I promise that we shall make this a key agenda in America, far beyond gays wanting to be married. I'm sure millions of blacks dying in Africa, in America and elsewhere is a much more important issue. It is crippling economies all across the African continent with millions of orphaned children and adults too sick to work and build economies.
http://www.aidanceproducts.com/Tetrasilver.html
Test Data
TETRASILVER has been studied for over 10 years, showing that it is, both, very effective and very safe in skin care applications.
In-Vitro Testing:
"In-vitro" means an artificial environment created outside a living organism (e.g., a test tube or culture plate) used in experimental research to study a disease or process. Before tetraSILVER became our products’ unique ingredient it was tested by 14 independent research labs against gram-negative bacteria, gram-positive bacteria, fungi, yeast, and viruses. The labs included Quintiles, Parexel, MDS/Pharma, and other world renowned research organizations. Test after test documented the powerful antimicrobial properties of tetraSILVER.
Toxicity Testing:
In 1966, the US Environmental Protection Agency (EPA) approved tetraSILVER as an effective disinfectant in swimming pools, after extensive tests showed this Silver Oxide was capable of quickly killing a wide spectrum of germs. In the same series of studies, the EPA also determined that TetraSILVER was safe, after passing a series of oral (swallowing), dermal (skin), and ocular (eye) toxicity tests. These tests were very important because some people are in pools every day.
Clinical Testing:
Initial clinical investigations with 328 people (conducted by research dermatologists), in addition to reports from doctors throughout the world, strongly suggest that TetraSILVER, as a key ingredient in skin care products, provides outstanding benefits and supports the body's ability to quickly resolve many common skin problems.
http://www.compassion-response.net/15Promotional%20Articles/Magazine%20article%203pp.htm
Curing AIDS with tetrasilver tetroxide
molecular crystal devices
Compassion Response Network developed action projects in both Kinshasa and Harare. In all, once adequately funded, the projects would treat 43
advanced AIDS patients over six months, each patient being on one of nine alternative treatments for HIV/AIDS;
Zapper + colloidal silver + ozonated water, Dr Bob Beck treatment, Tetrasil/Imusil, Essiac formula, Flor Essence, Aurea Cento Spice Oils, Glyco-nutritional supplements, Absolutely pure colloidal silver + Oxyrich, Sutherlandia herb.
Each of these treatments has impressive claims for treating HIV/AIDS, but we remain impartial and detached from those claims.
Our task is to provide an independent comparative assessment of many alternative treatments for HIV/AIDS, something we believe had never been
done before. A daily nutritious meal would be provided to each of the patients (for otherwise many were so poor that once they were half better they would need to go and look for work simply to eat.)
The treatments were donated or provided for free, and the networking facilitators within Compassion Response Network serve on a voluntary
basis. However conditions in Africa are difficult and to do things properly various expenses would arise, food, transport, wages for cooks
and staff to provide treatments, comprehensive blood testing every two months of treatment and miscellaneous costs.
Blood tests would involve state of the art medical tests; bDNA viral load, CD4 immunity tests, full blood count and several other tests pre-treatment and at every 2-month stage of the 6 months of treatment.
http://msgboard.snopes.com/message/ultimatebb.php?/ubb/get_topic/f/76/t/001200/p/1.html
12 May, 2004 06:00 PM
I'm sure we'd covered this before, but I can't find anything about it through searches.
The patent
The obligitory excitable spam mail
The company website
13 May, 2004 09:16 AM
As soon as I spotten Dusenberg's name in the links, I knew we were dealing with fringe science. These hucksters tack "TETRASIL is currently sold without FDA approval as a no-claim product" in an effort to avoid the FDA approval process, and then make treatment claims for the product: "treat a variety of bacterial, viral, fungal and other skin conditions". Sorry, but any firm that doesn't want to prove that their product works and won't hurt me in the process doesn't get my business. Posts: 88 | From: Metro DC | Registered: Jan 2003 | IP: Logged | Report this post to a moderator
SoToasty
13 May, 2004 11:00 AM
Wow, This stuff is a miracle. It kills bacteria, fungus and viri. Amazing. When/where can I get some stock in the company. This cure-all should not be suppressed by the FDA. They should approve it NOW.
14 May, 2004 04:00 AM
Here's an idea: instead of clinical trials, let's have Xtreme Pharmaceuticals - a reality show where contestants with a range of conditions, from life threatening to minor, take an unidentified substance to see if it helps or hurts them.
Watch the bodybuilder's liver implode! Share the drama of the little old lady with arthritis as she realizes she'll never see her grandkids graduate. Jeer the male model with mild acne that winds up disfiguring himself.
There can be twists - when a drug is found that actually works, the contestant has to select their drug from several different sources - which is from an inspected US factory? - which is from an uninspected factory in China? - which was concocted in a garage in Arizona?
Call my agent! Call your attorney!
14 May, 2004 09:06 AM
Chemical Names:(Common Name, Synonym, Trade Names)
CAS REG. NO. 1301-96-8
CAS REG. NO. 155645-89-9
DIVALENT SILVER OXIDE (SILVER II OXIDE)
SILDATE
SILVER OXIDE (AG4O4)
SILVER(II) OXIDE
TETRASILVER TETRAOXIDE (AG4O4)
It is legal to use it in the US--it has been registered since 1996 by the US EPA as a pesticide to disinfect swimming pools and hot tubs. You can buy it as SilSpa and SilDate. That means the registrant had to prove it controls bacteria in pools & spas, as the label claims. The label also talks about not drinking the stuff.
Controlling bacteria in water is a far cry from curing AIDS in people. I found a lot of good studies where silver oxide is being evaluated as a surface coating on medical devices, such as urinary catheters, and may be a good disinfectant for that.
December, 2004 09:35 PM
I've used Tetrasil and it works. It's the best anti-fungal cream I've ever used. Athletes foot gone on day 2, and it never came back.
People who say the people making it are evil for making false claim and providing false hope know nothing.
There have been clinical trials regarding AIDS patients and Tetrasil does work as claimed.